Pricing Log in Create free account

CytoMed Therapeutics Limited (GDTC) vs Lisata Therapeutics, Inc. (LSTA)

CytoMed Therapeutics Limited and Lisata Therapeutics, Inc. are both Biotechnology companies. CytoMed Therapeutics Limited and Lisata Therapeutics, Inc. are of similar size ($10.3M and $9.6M). Across the 10 metrics below, CytoMed Therapeutics Limited leads on 6 and Lisata Therapeutics, Inc. on 4.

Valuation

Metric GDTC LSTA Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.62 9.71
P/B 0.57 1.17 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 0.14 9.21
Earnings yield (31.82%) (159.22%) (33.15%)
Free cash flow yield (0.38%) (131.69%) (25.50%)

Profitability

Metric GDTC LSTA Biotechnology median
Gross margin 0.00% 0.49% 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (101.66%) (56.36%)
Return on assets 0.00% (80.81%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GDTC LSTA Biotechnology median
Revenue growth (TTM) — (24.67%) 6.02%
EPS growth (last fiscal year) (68.75%) 20.42% 30.26%
Revenue growth, 5-year CAGR — (20.28%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GDTC LSTA Biotechnology median
Debt to equity 0.08 0.00 0.00
Current ratio 2.64 3.69 4.72
Net debt to EBITDA 0.86 0.88 0.96

Dividend

Metric GDTC LSTA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GDTC LSTA Biotechnology median
Market cap 10.30m 9.64m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack